Significance: The molecular events that promote the development of pulmonary
hypertension (PH) are complex and incompletely understood. The complex interplay …

Pulmonary hypertension (PH), increasingly recognized as a major health burden, remains
underdiagnosed due mainly to the unspecific symptoms. Pulmonary arterial hypertension …

Background Pulmonary hypertension is a disabling and life-threatening cardiovascular
disease. Early detection of elevated pulmonary artery pressure (ePAP) is needed for prompt …

The diagnosis of pulmonary arterial hypertension (PAH) is frequently delayed. We
hypothesized that circulating angiogenic modulatory protein levels might correspond with …

In the last decades, important advances have been made in the treatment of pulmonary
arterial hypertension (PAH), a severe, progressive, incurable, and potentially fatal disease …

Purpose The aim of this scoping review is to understand the motivations for the creation of
global medical curricula, summarize methods that have been used to create these curricula …

Portopulmonary hypertension (POPH) is a severe pulmonary vascular disease secondary to
portal hypertension and a subset of Group 1 pulmonary hypertension (PH). The pathological …

Pulmonary vascular disease (PVD) is a significant global health problem and accounts for a
substantial portion of cardiovascular disease in the developing world. Although there have …

Chronic liver disease and/or portal hypertension may be associated with one of the two
pulmonary vascular complications: portopulmonary hypertension and hepatopulmonary …

Objective To examine how select Veterans Health Administration (VA) sites organized care
for patients with pulmonary hypertension (PH), with a focus on describing existing practices …